| |DECEMBER 20241`150THEINDUSTRYOUTLOOK.COMDECEMBER, 2024PHARMA IPR CONSULTANTSDr. Upendra K. Jain, Founder & CEOStrengthening Pharmacovigilance & Risk ManagementINDIVIRTUSINDIVIRTUS
Page 2 >